Sodium-Glucose linked transporter 2 (SGLT2) inhibitors--fighting diabetes from a new perspective.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Works matching IS 0741238X AND DT 2014 AND VI 31 AND IP 6
Results: 7
1
2
The clinical impact of different coagulometers on patient outcomes.
- Published in:
- 2014
- By:
- Publication type:
- journal article
3
24-Hour Efficacy of Travoprost/Timolol BAK-Free Versus Latanoprost/Timolol Fixed Combinations in Patients Insufficiently Controlled with Latanoprost.
- Published in:
- Advances in Therapy, 2014, v. 31, n. 6, p. 592, doi. 10.1007/s12325-014-0125-9
- By:
- Publication type:
- Article
4
Empagliflozin Monotherapy in Japanese Patients with Type 2 Diabetes Mellitus: a Randomized, 12-Week, Double-Blind, Placebo-Controlled, Phase II Trial.
- Published in:
- Advances in Therapy, 2014, v. 31, n. 6, p. 621, doi. 10.1007/s12325-014-0126-8
- By:
- Publication type:
- Article
5
Sodium-Glucose Linked Transporter 2 (SGLT2) Inhibitors-Fighting Diabetes from a New Perspective.
- Published in:
- Advances in Therapy, 2014, v. 31, n. 6, p. 579, doi. 10.1007/s12325-014-0127-7
- By:
- Publication type:
- Article
6
Safety and Tolerability of Tapentadol Extended Release in Moderate to Severe Chronic Osteoarthritis or Low Back Pain Management: Pooled Analysis of Randomized Controlled Trials.
- Published in:
- Advances in Therapy, 2014, v. 31, n. 6, p. 604, doi. 10.1007/s12325-014-0128-6
- By:
- Publication type:
- Article
7
The Clinical Impact of Different Coagulometers on Patient Outcomes.
- Published in:
- Advances in Therapy, 2014, v. 31, n. 6, p. 639, doi. 10.1007/s12325-014-0124-x
- By:
- Publication type:
- Article